Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.
Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group. Ramos-Casals M, et al. Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30. Clin Exp Rheumatol. 2010. PMID: 20525449
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label.
Díaz-Lagares C, Pérez-Alvarez R, García-Hernández FJ, Ayala-Gutiérrez MM, Callejas JL, Martínez-Berriotxoa A, Rascón J, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Gómez-de-la-Torre R, Sáez L, Canora-Lebrato J, Camps MT, Ortego-Centeno N, Castillo-Palma MJ, Ramos-Casals M; BIOGEAS Study Group. Díaz-Lagares C, et al. Arthritis Res Ther. 2011 Jul 11;13(4):R112. doi: 10.1186/ar3397. Arthritis Res Ther. 2011. PMID: 21745378 Free PMC article.
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Díaz-Lagares C, Croca S, Sangle S, Vital EM, Catapano F, Martínez-Berriotxoa A, García-Hernández F, Callejas-Rubio JL, Rascón J, D'Cruz D, Jayne D, Ruiz-Irastorza G, Emery P, Isenberg D, Ramos-Casals M, Khamashta MA; UK-BIOGEAS Registry. Díaz-Lagares C, et al. Autoimmun Rev. 2012 Mar;11(5):357-64. doi: 10.1016/j.autrev.2011.10.009. Epub 2011 Oct 18. Autoimmun Rev. 2012. PMID: 22032879
Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus.
Sánchez E, Callejas-Rubio JL, Sabio JM, Gónzalez-Gay MA, Jimenez-Alonso J, Micó L, de Ramón E, Camps M, Suarez A, Gutierrez C, Garcia-Portales R, Tolosa C, Ortego-Centeno N, Sánchez-Román J, Garcia-Hernández FJ, Gónzalez-Escribano MF, Martin J. Sánchez E, et al. Clin Exp Rheumatol. 2009 Mar-Apr;27(2):267-71. Clin Exp Rheumatol. 2009. PMID: 19473567
[Rituximab for treatment of patients with systemic autoimmune diseases].
García Hernández FJ, Ocaña Medina C, González León R, Garrido Rasco R, Colorado Bonilla R, Castillo Palma MJ, Sánchez Román J. García Hernández FJ, et al. Med Clin (Barc). 2007 Mar 31;128(12):458-62. doi: 10.1157/13100563. Med Clin (Barc). 2007. PMID: 17408540 Spanish.
Association between -174 interleukin-6 gene polymorphism and biological response to rituximab in several systemic autoimmune diseases.
Robledo G, Dávila-Fajardo CL, Márquez A, Ortego-Centeno N, Callejas Rubio JL, de Ramón Garrido E, Sánchez-Román J, García-Hernández FJ, Ríos-Fernández R, González-Escribano MF, Camps García MT, Castillo Palma MJ, Ayala Mdel M, Martín J. Robledo G, et al. DNA Cell Biol. 2012 Sep;31(9):1486-91. doi: 10.1089/dna.2012.1684. Epub 2012 Jun 26. DNA Cell Biol. 2012. PMID: 22734797
Anti-centromere antibodies in patients with systemic lupus erythematosus.
Respaldiza N, Wichmann I, Ocaña C, Garcia-Hernandez FJ, Castillo MJ, Magariño MI, Magariño R, Torres A, Sanchez-Roman J, Nuñez-Roldan A. Respaldiza N, et al. Scand J Rheumatol. 2006 Jul-Aug;35(4):290-4. doi: 10.1080/03009740600588376. Scand J Rheumatol. 2006. PMID: 16882593
166 results